Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma
2006

Leptin and its receptor genes linked to breast cancer risk

Sample size: 530 publication 10 minutes Evidence: high

Author Information

Author(s): Snoussi Kaouther, Strosberg A Donny, Bouaouina Noureddine, Ahmed Slim Ben, Helal A Noureddine, Chouchane Lotfi

Primary Institution: Laboratoire d'Immuno-Oncologie Moléculaire, Faculté de Médecine de Monastir, Université de Monastir, Tunisia

Hypothesis

Genetic variations in LEP and LEPR may influence susceptibility to and prognosis in breast carcinoma.

Conclusion

Polymorphisms in LEP and LEPR genes are associated with increased breast cancer risk and poorer prognosis.

Supporting Evidence

  • Carriers of the LEP (-2548) AA genotype have more than 3-fold risk to develop breast carcinoma.
  • The LEP (-2548) A allele frequency was significantly higher in the patient group compared to controls.
  • Patients with the LEPR 223R allele had significantly shorter overall survival.
  • Significant differences in disease-free survival were observed for patients carrying the LEP (-2548) A allele.

Takeaway

This study found that certain genetic changes in leptin and its receptor can make people more likely to get breast cancer and have a harder time fighting it.

Methodology

The study analyzed genetic variations in LEP and LEPR genes in 308 breast cancer patients and 222 healthy controls using PCR and restriction enzyme digestion.

Potential Biases

Potential selection bias due to the specific population and the nature of case-control studies.

Limitations

The study was limited to a specific population in Tunisia, which may affect the generalizability of the results.

Participant Demographics

308 breast cancer patients and 222 healthy controls from Tunisia, mean age of patients was 50 years.

Statistical Information

P-Value

0.001

Confidence Interval

[1.47–6.96]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-6-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication